# West Pharmaceutical Services Inc: filings

WST · NYSE · CIK 105770 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wst.md) · [Financials](/companies/wst/financials.md) · [Filings](/companies/wst/filings.md) · [Insiders](/companies/wst/insiders.md)

## Reports and events: 332 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1119, 8-K 233, 4/A 60, 10-Q 54, SC 13G/A 52, 3 36, 11-K 30, 10-K 18, DEF 14A 18, DEFA14A 17, SD 13, 144 8, ARS 8, SC 13G 8, 8-K/A 7, CT ORDER 7, 5 5, PRE 14A 5, S-8 4, SCHEDULE 13G 3, SCHEDULE 13G/A 3, S-8 POS 2, SC TO-I/A 2, UPLOAD 2, 10-K/A 1, 10-Q/A 1, 3/A 1, CORRESP 1, PX14A6G 1, SC TO-C 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:17 ET | [10-Q](/filings/0000105770-26-000121.md) | Quarterly report, period 2026-09-30 | 0000105770-26-000121 |
| 2026-10-29 | 07:06 ET | [8-K](/filings/0000105770-26-000118.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000118 |
| 2026-10-26 | 17:14 ET | [8-K](/filings/0000105770-26-000114.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000105770-26-000114 |
| 2026-07-23 | 16:15 ET | [10-Q](/filings/0000105770-26-000099.md) | Quarterly report, period 2026-06-30 | 0000105770-26-000099 |
| 2026-07-23 | 07:14 ET | [8-K](/filings/0000105770-26-000097.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000097 |
| 2026-07-14 | 16:29 ET | [8-K](/filings/0000105770-26-000093.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000105770-26-000093 |
| 2026-06-01 | 16:32 ET | [8-K](/filings/0000105770-26-000080.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000080 |
| 2026-05-20 | 16:04 ET | [8-K/A](/filings/0000105770-26-000077.md) | 1.05 Material cybersecurity incident; 9.01 Financial statements and exhibits | 0000105770-26-000077 |
| 2026-05-11 | 17:06 ET | [8-K](/filings/0000105770-26-000068.md) | 1.05 Material cybersecurity incident; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000068 |
| 2026-05-05 | 16:49 ET | [8-K](/filings/0000105770-26-000056.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-26-000056 |
| 2026-04-23 | 16:12 ET | [10-Q](/filings/0000105770-26-000049.md) | Quarterly report, period 2026-03-31 | 0000105770-26-000049 |
| 2026-04-23 | 07:11 ET | [8-K](/filings/0000105770-26-000047.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000047 |
| 2026-03-12 | 08:31 ET | [DEF 14A](/filings/0001104659-26-026778.md) | Proxy statement, period 2026-05-04 | 0001104659-26-026778 |
| 2026-03-09 | 16:33 ET | [8-K](/filings/0000105770-26-000041.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000041 |
| 2026-02-17 | 16:28 ET | [10-K](/filings/0000105770-26-000010.md) | Annual report, period 2025-12-31 | 0000105770-26-000010 |
| 2026-02-12 | 07:21 ET | [8-K](/filings/0000105770-26-000005.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-26-000005 |
| 2025-10-23 | 16:14 ET | [10-Q](/filings/0000105770-25-000093.md) | Quarterly report, period 2025-09-30 | 0000105770-25-000093 |
| 2025-10-23 | 07:15 ET | [8-K](/filings/0000105770-25-000090.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000090 |
| 2025-09-11 | 16:06 ET | [8-K](/filings/0000105770-25-000083.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000083 |
| 2025-07-24 | 16:22 ET | [10-Q](/filings/0000105770-25-000065.md) | Quarterly report, period 2025-06-30 | 0000105770-25-000065 |
| 2025-07-24 | 07:17 ET | [8-K](/filings/0000105770-25-000062.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000062 |
| 2025-07-21 | 16:17 ET | [8-K](/filings/0000105770-25-000058.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000058 |
| 2025-05-12 | 16:46 ET | [8-K/A](/filings/0000105770-25-000043.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000043 |
| 2025-05-08 | 16:46 ET | [8-K](/filings/0000105770-25-000039.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-25-000039 |
| 2025-04-24 | 16:19 ET | [10-Q](/filings/0000105770-25-000036.md) | Quarterly report, period 2025-03-31 | 0000105770-25-000036 |
| 2025-04-24 | 07:56 ET | [8-K](/filings/0000105770-25-000031.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000031 |
| 2025-04-24 | 07:47 ET | [8-K](/filings/0000105770-25-000029.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000029 |
| 2025-04-14 | 16:09 ET | [8-K](/filings/0000105770-25-000022.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000022 |
| 2025-03-21 | 16:05 ET | [DEF 14A](/filings/0001558370-25-003461.md) | Proxy statement, period 2025-05-06 | 0001558370-25-003461 |
| 2025-03-11 | 16:08 ET | [8-K](/filings/0000105770-25-000019.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-25-000019 |
| 2025-02-18 | 16:44 ET | [10-K](/filings/0000105770-25-000013.md) | Annual report, period 2024-12-31 | 0000105770-25-000013 |
| 2025-02-13 | 08:00 ET | [8-K](/filings/0000105770-25-000007.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-25-000007 |
| 2024-12-13 | 16:02 ET | [8-K](/filings/0000105770-24-000088.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000105770-24-000088 |
| 2024-12-11 | 16:11 ET | [8-K](/filings/0000105770-24-000084.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000084 |
| 2024-10-24 | 16:21 ET | [10-Q](/filings/0000105770-24-000081.md) | Quarterly report, period 2024-09-30 | 0000105770-24-000081 |
| 2024-10-24 | 07:50 ET | [8-K](/filings/0000105770-24-000075.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000075 |
| 2024-10-07 | 16:04 ET | [8-K](/filings/0000105770-24-000071.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000105770-24-000071 |
| 2024-07-25 | 16:10 ET | [10-Q](/filings/0000105770-24-000066.md) | Quarterly report, period 2024-06-30 | 0000105770-24-000066 |
| 2024-07-25 | 08:05 ET | [8-K](/filings/0000105770-24-000060.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000060 |
| 2024-07-08 | 07:56 ET | [8-K](/filings/0000105770-24-000055.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000105770-24-000055 |
| 2024-04-26 | 16:16 ET | [8-K](/filings/0000105770-24-000035.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-24-000035 |
| 2024-04-25 | 16:24 ET | [10-Q](/filings/0000105770-24-000031.md) | Quarterly report, period 2024-03-31 | 0000105770-24-000031 |
| 2024-04-25 | 07:42 ET | [8-K](/filings/0000105770-24-000025.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000025 |
| 2024-03-13 | 08:31 ET | [DEF 14A](/filings/0001558370-24-003056.md) | Proxy statement, period 2024-04-23 | 0001558370-24-003056 |
| 2024-02-20 | 16:44 ET | [10-K](/filings/0000105770-24-000015.md) | Annual report, period 2023-12-31 | 0000105770-24-000015 |
| 2024-02-15 | 07:51 ET | [8-K](/filings/0000105770-24-000009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-24-000009 |
| 2023-11-30 | 16:05 ET | [8-K](/filings/0000105770-23-000075.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000105770-23-000075 |
| 2023-10-26 | 16:26 ET | [10-Q](/filings/0000105770-23-000068.md) | Quarterly report, period 2023-09-30 | 0000105770-23-000068 |
| 2023-10-26 | 07:41 ET | [8-K](/filings/0000105770-23-000064.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000105770-23-000064 |
| 2023-09-21 | 16:33 ET | [8-K/A](/filings/0000105770-23-000054.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000105770-23-000054 |

Page 1 of 7. [Older](/companies/wst/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:13 ET. No prices; not investment advice.